{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T00:01:07Z","timestamp":1721347267572},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,2,12]],"date-time":"2019-02-12T00:00:00Z","timestamp":1549929600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,2,12]],"date-time":"2019-02-12T00:00:00Z","timestamp":1549929600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Osteoporos"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s11657-019-0571-8","type":"journal-article","created":{"date-parts":[[2019,2,12]],"date-time":"2019-02-12T20:06:19Z","timestamp":1550001979000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Rationale, study design, and descriptive data of the Lucky Bone\u2122 Fracture Liaison Service"],"prefix":"10.1007","volume":"14","author":[{"given":"Andr\u00e9a","family":"Senay","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvie","family":"Perreault","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9e","family":"Delisle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne N.","family":"Morin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Pierre","family":"Raynauld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreea","family":"Banica","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yves","family":"Troyanov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Beaumont","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alain","family":"Jodoin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. Yves","family":"Laflamme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phane","family":"Leduc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Marc","family":"Mac-Thiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Ranger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominique M.","family":"Rouleau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julio C.","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,2,12]]},"reference":[{"key":"571_CR1","first-page":"569","volume":"94","author":"National Institutes of Health","year":"2001","unstructured":"National Institutes of Health (2001) NIH consensus development panel on osteoporosis prevention, diagnosis, and therapy, March 7-29, 2000: highlights of the conference. South Med J 94:569\u2013573","journal-title":"South Med J"},{"key":"571_CR2","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1002\/jbmr.1952","volume":"28","author":"LA Ahmed","year":"2013","unstructured":"Ahmed LA, Center JR, Bjornerem A et al (2013) Progressively increasing fracture risk with advancing age after initial incident fragility fracture: the Tromso study. J Bone Miner Res 28:2214\u20132221","journal-title":"J Bone Miner Res"},{"key":"571_CR3","doi-asserted-by":"publisher","first-page":"171","DOI":"10.5312\/wjo.v7.i3.171","volume":"7","author":"P Pisani","year":"2016","unstructured":"Pisani P, Renna MD, Conversano F, Casciaro E, di Paola M, Quarta E, Muratore M, Casciaro S (2016) Major osteoporotic fragility fractures: risk factor updates and societal impact. World journal of orthopedics 7:171\u2013181","journal-title":"World journal of orthopedics"},{"key":"571_CR4","doi-asserted-by":"publisher","first-page":"h3783","DOI":"10.1136\/bmj.h3783","volume":"351","author":"S Maraka","year":"2015","unstructured":"Maraka S, Kennel KA (2015) Bisphosphonates for the prevention and treatment of osteoporosis. BMJ 351:h3783","journal-title":"BMJ"},{"key":"571_CR5","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.bone.2016.05.013","volume":"89","author":"J Sanderson","year":"2016","unstructured":"Sanderson J, Martyn-St James M, Stevens J, Goka E, Wong R, Campbell F, Selby P, Gittoes N, Davis S (2016) Clinical effectiveness of bisphosphonates for the prevention of fragility fractures: a systematic review and network meta-analysis. Bone 89:52\u201358","journal-title":"Bone"},{"key":"571_CR6","doi-asserted-by":"publisher","first-page":"3289","DOI":"10.1007\/s00198-017-4175-0","volume":"28","author":"T Saito","year":"2017","unstructured":"Saito T, Sterbenz JM, Malay S, Zhong L, MacEachern MP, Chung KC (2017) Effectiveness of anti-osteoporotic drugs to prevent secondary fragility fractures: systematic review and meta-analysis. Osteoporos Int 28:3289\u20133300","journal-title":"Osteoporos Int"},{"key":"571_CR7","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1007\/s00198-011-1630-1","volume":"23","author":"WD Leslie","year":"2012","unstructured":"Leslie WD, Giangregorio LM, Yogendran M, Azimaee M, Morin S, Metge C, Caetano P, Lix LM (2012) A population-based analysis of the post-fracture care gap 1996\u20132008: the situation is not improving. Osteoporos Int 23:1623\u20131629","journal-title":"Osteoporos Int"},{"key":"571_CR8","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.amjmed.2017.02.042","volume":"130","author":"M Sattari","year":"2017","unstructured":"Sattari M, Cauley JA, Garvan C, Johnson KC, LaMonte MJ, Li W, Limacher M, Manini T, Sarto GE, Sullivan SD, Wactawski-Wende J, Beyth RJ (2017) Osteoporosis in the Women\u2019s Health Initiative: another treatment gap? Am J Med 130:937\u2013948","journal-title":"Am J Med"},{"key":"571_CR9","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s11657-017-0316-5","volume":"12","author":"E Durden","year":"2017","unstructured":"Durden E, Pinto L, Lopez-Gonzalez L, Juneau P, Barron R (2017) Two-year persistence and compliance with osteoporosis therapies among postmenopausal women in a commercially insured population in the United States. Arch Osteoporos 12:22","journal-title":"Arch Osteoporos"},{"key":"571_CR10","unstructured":"(2014) Institut national d\u2019excellence en sant\u00e9 et en services sociaux (INESSS). Portrait de l\u2019usage des bisphosphonates et du d\u00e9nosumab chez les personnes de 50 ans ou plus souffrant d\u2019ost\u00e9oporose couvertes par le r\u00e9gime public d\u2019assurance m\u00e9dicaments. Portrait d\u2019usage r\u00e9dig\u00e9 par \u00c9ric Tremblay. Qu\u00e9bec, Qc : INESSS2014. p. 99p"},{"key":"571_CR11","doi-asserted-by":"publisher","first-page":"380","DOI":"10.7326\/0003-4819-152-6-201003160-00008","volume":"152","author":"P Haentjens","year":"2010","unstructured":"Haentjens P, Magaziner J, Colon-Emeric CS et al (2010) Meta-analysis: excess mortality after hip fracture among older women and men. Ann Intern Med 152:380\u2013390","journal-title":"Ann Intern Med"},{"key":"571_CR12","doi-asserted-by":"publisher","first-page":"3023","DOI":"10.1007\/s00198-016-3631-6","volume":"27","author":"RB Hopkins","year":"2016","unstructured":"Hopkins RB, Burke N, Von Keyserlingk C et al (2016) The current economic burden of illness of osteoporosis in Canada. Osteoporos Int 27:3023\u20133032. https:\/\/doi.org\/10.1007\/s00198-016-3631-6","journal-title":"Osteoporos Int"},{"key":"571_CR13","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1007\/s00198-013-2348-z","volume":"24","author":"K Akesson","year":"2013","unstructured":"Akesson K, Marsh D, Mitchell PJ et al (2013) Capture the fracture: a best practice framework and global campaign to break the fragility fracture cycle. Osteoporos Int 24:2135\u20132152","journal-title":"Osteoporos Int"},{"key":"571_CR14","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.1007\/s00198-015-3192-0","volume":"26","author":"MK Javaid","year":"2015","unstructured":"Javaid MK, Kyer C, Mitchell PJ et al (2015) Effective secondary fracture prevention: implementation of a global benchmarking of clinical quality using the IOF capture the fracture(R) best practice framework tool. Osteoporos Int 26:2573\u20132578","journal-title":"Osteoporos Int"},{"key":"571_CR15","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s00198-012-2090-y","volume":"24","author":"K Ganda","year":"2013","unstructured":"Ganda K, Puech M, Chen JS, Speerin R, Bleasel J, Center JR, Eisman JA, March L, Seibel MJ (2013) Models of care for the secondary prevention of osteoporotic fractures: a systematic review and meta-analysis. Osteoporos Int 24:393\u2013406","journal-title":"Osteoporos Int"},{"key":"571_CR16","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s11914-013-0177-9","volume":"11","author":"JR Curtis","year":"2013","unstructured":"Curtis JR, Silverman SL (2013) Commentary: the five Ws of a fracture liaison service: why, who, what, where, and how? In osteoporosis, we reap what we sow. Curr Osteoporos Rep 11:365\u2013368","journal-title":"Curr Osteoporos Rep"},{"key":"571_CR17","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1002\/jbmr.3437","volume":"33","author":"S Nayak","year":"2018","unstructured":"Nayak S, Greenspan SL (2018) How can we improve osteoporosis care? A systematic review and meta-analysis of the efficacy of quality improvement strategies for osteoporosis. J Bone Miner Res 33:1585\u20131594. https:\/\/doi.org\/10.1002\/jbmr.3437","journal-title":"J Bone Miner Res"},{"key":"571_CR18","doi-asserted-by":"publisher","first-page":"117","DOI":"10.2147\/CIA.S85551","volume":"12","author":"S Walters","year":"2017","unstructured":"Walters S, Khan T, Ong T, Sahota O (2017) Fracture liaison services: improving outcomes for patients with osteoporosis. Clin Interv Aging 12:117\u2013127","journal-title":"Clin Interv Aging"},{"key":"571_CR19","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1007\/s00198-013-2610-4","volume":"25","author":"K Ganda","year":"2014","unstructured":"Ganda K, Schaffer A, Pearson S, Seibel MJ (2014) Compliance and persistence to oral bisphosphonate therapy following initiation within a secondary fracture prevention program: a randomised controlled trial of specialist vs. non-specialist management. Osteoporos Int 25:1345\u20131355","journal-title":"Osteoporos Int"},{"key":"571_CR20","doi-asserted-by":"publisher","first-page":"e9012","DOI":"10.1097\/MD.0000000000009012","volume":"96","author":"DE Beaton","year":"2017","unstructured":"Beaton DE, Mamdani M, Zheng H, Jaglal S, Cadarette SM, Bogoch ER, Sale JEM, Sujic R, Jain R, Ontario Osteoporosis Strategy Fracture Clinic Screening Program Evaluation Team (2017) Improvements in osteoporosis testing and care are found following the wide scale implementation of the Ontario Fracture Clinic Screening Program: an interrupted time series analysis. Medicine (Baltimore) 96:e9012","journal-title":"Medicine (Baltimore)"},{"key":"571_CR21","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1503\/cmaj.100771","volume":"182","author":"A Papaioannou","year":"2010","unstructured":"Papaioannou A, Morin S, Cheung AM, Atkinson S, Brown JP, Feldman S, Hanley DA, Hodsman A, Jamal SA, Kaiser SM, Kvern B, Siminoski K, Leslie WD, for the Scientific Advisory Council of Osteoporosis Canada (2010) 2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary. CMAJ 182:1864\u20131873","journal-title":"CMAJ"},{"key":"571_CR22","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1007\/s00198-015-3413-6","volume":"27","author":"A Senay","year":"2016","unstructured":"Senay A, Delisle J, Raynauld JP, Morin SN, Fernandes JC (2016) Agreement between physicians\u2019 and nurses\u2019 clinical decisions for the management of the fracture liaison service (4iFLS): the Lucky Bone program. Osteoporos Int 27:1569\u20131576","journal-title":"Osteoporos Int"},{"key":"571_CR23","first-page":"S1","volume":"167","author":"JP Brown","year":"2002","unstructured":"Brown JP, Josse RG (2002) 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. CMAJ 167:S1\u2013S34","journal-title":"CMAJ"},{"key":"571_CR24","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.clinbiochem.2009.04.001","volume":"42","author":"JP Brown","year":"2009","unstructured":"Brown JP, Albert C, Nassar BA, Adachi JD, Cole D, Davison KS, Dooley KC, Don-Wauchope A, Douville P, Hanley DA, Jamal SA, Josse R, Kaiser S, Krahn J, Krause R, Kremer R, Lepage R, Letendre E, Morin S, Ooi DS, Papaioaonnou A, Ste-Marie LG (2009) Bone turnover markers in the management of postmenopausal osteoporosis. Clin Biochem 42:929\u2013942","journal-title":"Clin Biochem"},{"key":"571_CR25","unstructured":"(1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO study group. World Health Organ Tech Rep Ser 843:1\u2013129"},{"key":"571_CR26","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.carj.2011.05.001","volume":"62","author":"B Lentle","year":"2011","unstructured":"Lentle B, Cheung AM, Hanley DA, Leslie WD, Lyons D, Papaioannou A, Atkinson S, Brown JP, Feldman S, Hodsman AB, Jamal AS, Josse RG, Kaiser SM, Kvern B, Morin S, Siminoski K, Scientific Advisory Council of Osteoporosis Canada (2011) Osteoporosis Canada 2010 guidelines for the assessment of fracture risk. Can Assoc Radiol J 62:243\u2013250","journal-title":"Can Assoc Radiol J"},{"key":"571_CR27","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/S0895-4356(98)00109-7","volume":"51","author":"B Gandek","year":"1998","unstructured":"Gandek B, Ware JE, Aaronson NK, Apolone G, Bjorner JB, Brazier JE, Bullinger M, Kaasa S, Leplege A, Prieto L, Sullivan M (1998) Cross-validation of item selection and scoring for the SF-12 health survey in nine countries: results from the IQOLA Project. J Clin Epidemiol 51:1171\u20131178","journal-title":"J Clin Epidemiol"},{"key":"571_CR28","doi-asserted-by":"crossref","unstructured":"Hawker GA, Mian S, Kendzerska T, French M (2011) Measures of adult pain: visual analog scale for pain (VAS pain), numeric rating scale for pain (NRS pain), McGill pain questionnaire (MPQ), short-form McGill pain questionnaire (SF-MPQ), chronic pain grade scale (CPGS), short Form-36 bodily pain scale (SF-36 BPS), and measure of intermittent and constant osteoarthritis pain (ICOAP). Arthritis Care Res (Hoboken) 63:S240-S252","DOI":"10.1002\/acr.20543"},{"key":"571_CR29","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1471-2474-4-11","volume":"4","author":"C Gummesson","year":"2003","unstructured":"Gummesson C, Atroshi I, Ekdahl C (2003) The disabilities of the arm, shoulder and hand (DASH) outcome questionnaire: longitudinal construct validity and measuring self-rated health change after surgery. BMC Musculoskelet Disord 4:11","journal-title":"BMC Musculoskelet Disord"},{"key":"571_CR30","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1177\/2151458515604715","volume":"6","author":"S Goldhahn","year":"2015","unstructured":"Goldhahn S, Kach K, Frei HC et al (2015) Cross-cultural adaptation and validation of the lower extremity measure into German. Geriatr Orthop Surg Rehabil 6:282\u2013288","journal-title":"Geriatr Orthop Surg Rehabil"},{"key":"571_CR31","doi-asserted-by":"publisher","first-page":"2559","DOI":"10.1007\/978-3-642-28753-4_3021","volume-title":"Encyclopedia of pain","author":"O Haegg","year":"2013","unstructured":"Haegg O (2013) Oswestry disability index. In: Gebhart GF, Schmidt RF (eds) Encyclopedia of pain. Springer Berlin Heidelberg, Berlin, pp 2559\u20132562. https:\/\/doi.org\/10.1007\/978-3-642-28753-4_3021"},{"key":"571_CR32","first-page":"107","volume":"2016\u20132017","author":"R\u00e9gie de l\u2019assurance maladie du Qu\u00e9bec","year":"2017","unstructured":"R\u00e9gie de l\u2019assurance maladie du Qu\u00e9bec (2017) Rapport annuel de gestion 2016\u20132017:107\u2013112","journal-title":"Rapport annuel de gestion"},{"key":"571_CR33","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S0895-4356(99)00136-5","volume":"53","author":"R Tamblyn","year":"2000","unstructured":"Tamblyn R, Reid T, Mayo N, McLeod P, Churchill-Smith M (2000) Using medical services claims to assess injuries in the elderly: sensitivity of diagnostic and procedure codes for injury ascertainment. J Clin Epidemiol 53:183\u2013194","journal-title":"J Clin Epidemiol"},{"key":"571_CR34","unstructured":"R\u00e9seau Qu\u00e9b\u00e9cois de Recherche sur les M\u00e9dicaments (RQRM). reMed : Data Registry for Prescribed Medications \/ Banque de donn\u00e9es sur les m\u00e9dicaments d'ordonnance.doi. Available from: www.rqrm.ca\/plateformes\/optimisation-de-l-usage\/64-4-remed-data-registry-for-prescribed-medications-banque-de-donnees-sur-les-medicaments-d-ordonnance.html . Accessed 5 June 2018"},{"key":"571_CR35","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373\u2013383","journal-title":"J Chronic Dis"},{"key":"571_CR36","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1016\/j.jclinepi.2004.03.012","volume":"57","author":"V Sundararajan","year":"2004","unstructured":"Sundararajan V, Henderson T, Perry C, Muggivan A, Quan H, Ghali WA (2004) New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality. J Clin Epidemiol 57:1288\u20131294","journal-title":"J Clin Epidemiol"},{"key":"571_CR37","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1007\/s00198-015-3253-4","volume":"26","author":"L Karlsson","year":"2015","unstructured":"Karlsson L, Lundkvist J, Psachoulia E, Intorcia M, Strom O (2015) Persistence with denosumab and persistence with oral bisphosphonates for the treatment of postmenopausal osteoporosis: a retrospective, observational study, and a meta-analysis. Osteoporos Int 26:2401\u20132411","journal-title":"Osteoporos Int"},{"key":"571_CR38","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1210\/jc.2010-2704","volume":"96","author":"AC Ross","year":"2011","unstructured":"Ross AC, Manson JE, Abrams SA et al (2011) The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 96:53\u201358","journal-title":"J Clin Endocrinol Metab"},{"key":"571_CR39","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s00198-011-1559-4","volume":"23","author":"S Jean","year":"2012","unstructured":"Jean S, Candas B, Belzile E, Morin S, Bessette L, Dodin S, Brown JP (2012) Algorithms can be used to identify fragility fracture cases in physician-claims databases. Osteoporos Int 23:483\u2013501","journal-title":"Osteoporos Int"},{"key":"571_CR40","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1037\/a0012765","volume":"53","author":"OM Kwok","year":"2008","unstructured":"Kwok OM, Underhill AT, Berry JW, Luo W, Elliott TR, Yoon M (2008) Analyzing longitudinal data with multilevel models: an example with individuals living with lower extremity intra-articular fractures. Rehabil Psychol 53:370\u2013386","journal-title":"Rehabil Psychol"},{"key":"571_CR41","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1080\/02664763.2016.1141181","volume":"43","author":"D Lai","year":"2016","unstructured":"Lai D, Xu H, Koller D, Foroud T, Gao S (2016) A multivariate finite mixture latent trajectory model with application to dementia studies. J Appl Stat 43:2503\u20132523","journal-title":"J Appl Stat"},{"key":"571_CR42","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1177\/0165025409343765","volume":"33","author":"N Ram","year":"2009","unstructured":"Ram N, Grimm KJ (2009) Growth mixture modeling: a method for identifying differences in longitudinal change among unobserved groups. Int J Behav Dev 33:565\u2013576","journal-title":"Int J Behav Dev"},{"key":"571_CR43","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.1007\/s00198-013-2368-8","volume":"24","author":"M Chandran","year":"2013","unstructured":"Chandran M, Tan MZ, Cheen M et al (2013) Secondary prevention of osteoporotic fractures--an \u201cOPTIMAL\u201d model of care from Singapore. Osteoporos Int 24:2809\u20132817","journal-title":"Osteoporos Int"}],"container-title":["Archives of Osteoporosis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11657-019-0571-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11657-019-0571-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11657-019-0571-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T19:01:00Z","timestamp":1720983660000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11657-019-0571-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,12]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["571"],"URL":"https:\/\/doi.org\/10.1007\/s11657-019-0571-8","relation":{},"ISSN":["1862-3522","1862-3514"],"issn-type":[{"value":"1862-3522","type":"print"},{"value":"1862-3514","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,12]]},"assertion":[{"value":"12 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures performed in this study involving human participants were in accordance with the ethical standards of the CIUSSS Nord de l\u2019Ile de Montr\u00e9al ethic research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Senay, Perreault, Banica, Beaumont, Jodoin, and Nguyen declare that they have no conflict of interest. Delisle reports support for personal fees from Amgen Canada and Eli Lilly outside of the conducted work. Morin reports grants from Amgen Canada and Merck, support as an advisory board member from Amgen Canada and Eli Lilly outside of the conducted work. Raynauld reports fees as an advisory board member for Amgen Canada outside of the conducted work. Troyanov reports fees as an advisory board member for Amgen, Eli Lilly, and Novartis outside of the conducted work. Laflamme reports research grants from Zimmer, Stryker, and DePuy Synthes, and support as a consultant from Stryker outside of the conducted work. Leduc reports research grants from Stryker, DePuy Synthes, Smith & Nephew, and Zimmer, and support as a consultant from Stryker outside of the conducted work. Mac-Thiong reports acts as co-founder of Spinologics Inc. and head of Medtronic Research Chair outside of the conducted work. Ranger reports grants from Johnson & Johnson, support as a consultant from Smith & Nephew, Corin, Bioventus, Sanofi Canada, and support for development of educational presentations by Horizon Pharma outside of the conducted work. Rouleau reports research and educational grants from Zimmer, Stryker, Smith & Nephew, Tornier, Arthrex, Conmed, and DePuy Synthes outside of the conducted work. Fernandes reports grants from Eli Lilly during the conduct of this study and grants from Baxter outside of the conducted work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}],"article-number":"19"}}